Sale!

Oncopro Tumor Mutation Burden TMB Test

Original price was: 15,600 د.إ.Current price is: 14,040 د.إ.

-10%

The Oncopro Tumor Mutation Burden (TMB) Test is a cutting-edge diagnostic tool available at DNA Labs UAE, designed to assess the number of mutations within a tumor’s DNA. This test plays a crucial role in the field of oncology, as the Tumor Mutation Burden is a biomarker that can predict how well a patient might respond to certain immunotherapies. By evaluating the quantity of mutations, the test can help oncologists tailor more effective and personalized treatment plans for patients with various types of cancer.

The test involves a comprehensive analysis of the tumor tissue to quantify the mutation burden, providing valuable insights into the tumor’s behavior and its potential response to treatment. This information is pivotal for determining the suitability of immunotherapy, which works by empowering the patient’s immune system to recognize and combat cancer cells more effectively.

Administered at DNA Labs UAE, a facility known for its advanced diagnostic technologies and precision medicine, the Oncopro TMB Test is available for a cost of 14,040 AED. This investment can be a crucial step for patients seeking personalized cancer therapy options, offering a beacon of hope for improved treatment outcomes by leveraging the power of genetic insights to combat cancer.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ONCOPRO TUMOR MUTATION BURDEN (TMB) Test

Are you looking for a reliable genetic lab in UAE for ONCOPRO TUMOR MUTATION BURDEN (TMB) Test? Look no further than DNA Labs UAE. We offer accurate and affordable genetic testing services, including the TMB test, which can provide valuable insights into a patient’s tumor mutations.

Test Details

The ONCOPRO Tumor Mutation Burden (TMB) Test is a diagnostic test that measures the number of mutations present in a patient’s tumor. TMB is an emerging biomarker that has been shown to predict response to immunotherapy in certain types of cancer. The test is typically performed on a tissue sample from the patient’s tumor and uses next-generation sequencing (NGS) technology to identify and quantify mutations. The results of the test can help guide treatment decisions and may be used to identify patients who are likely to benefit from immunotherapy.

Test Components and Cost

  • Test Name: ONCOPRO TUMOR MUTATION BURDEN (TMB) Test
  • Components: NGS
  • Price: 14040.0 AED

Sample Condition and Submission

To perform the TMB test, please submit a formalin-fixed paraffin-embedded block (FFPE) of the tumor tissue. The block should have at least 10% tumor tissue. Additionally, provide a copy of the Histopathology report and duly filled NGS Test Requisition Form. The sample should be shipped at room temperature.

Report Delivery

The sample should be submitted by Tuesday at 11 am. The report will be delivered within 15 working days.

Doctor and Test Department

  • Doctor: Oncologist
  • Test Department: Molecular Diagnostics

Pre-Test Information

Before conducting the TMB test, it is essential to provide a copy of the Histopathology report and duly filled NGS Test Requisition Form.

At DNA Labs UAE, we prioritize accuracy and reliability in our genetic testing services. Contact us today to schedule your ONCOPRO TUMOR MUTATION BURDEN (TMB) Test and gain valuable insights into your cancer treatment options.

Test Name ONCOPRO TUMOR MUTATION BURDEN TMB Test
Components
Price 14040.0 AED
Sample Condition Submit formalin fixed paraffin embedded block (FFPE). Ship at room temperature. Block should have atleast 10% tumor tissue. Provide a copy of the Histopathology report. Duly filled NGS Test Requisition Formis mandatory.\n.
Report Delivery Sample Tue by 11 am; Report 15 Working days
Method NGS
Test type Cancer
Doctor Oncologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information Provide a copy of the Histopathology report. Duly filled NGS Test Requisition Formis mandatory.
Test Details

The ONCOPRO Tumor Mutation Burden (TMB) Test is a diagnostic test that measures the number of mutations present in a patient’s tumor. TMB is an emerging biomarker that has been shown to predict response to immunotherapy in certain types of cancer. The test is typically performed on a tissue sample from the patient’s tumor and uses next-generation sequencing technology to identify and quantify mutations. The results of the test can help guide treatment decisions and may be used to identify patients who are likely to benefit from immunotherapy.